MENU

Fox Chase Cancer Center News

Dr. Martin was at Fox Chase Cancer Center/Temple University for a three-year fellowship in hematology/oncology, 2016-2019.
July 3, 2019

Fox Chase Cancer Center Welcomes Assistant Professor James Martin

PHILADELPHIA (July 3, 2019) – Fox Chase Cancer Center is pleased to announce the hiring of James M. Martin, MD, who will join the faculty as assistant professor in the Hematology and Bone Marrow Transplant Programs within the Department of Hematology/Oncology.

June 28, 2019

Fox Chase Cancer Center Welcomes New Pathologist Nicholas Mackrides

PHILADELPHIA (June 28, 2019) – Fox Chase Cancer Center announces the hiring of Nicholas Mackrides, MD, who will join the faculty as a clinical instructor in the Department of Pathology.

June 27, 2019

New Kinase Nomenclature Could Aid in Design of Cancer Drug Inhibitors

PHILADELPHIA (June 27, 2019) – Researchers at Fox Chase Cancer Center have developed a new classification scheme and nomenclature for the structural states of protein kinases, which play an important role in signaling pathways and can be targeted by cancer treatments.

Josh Meyer, Radiation Oncology
June 26, 2019

Differences in Genomic Landscape of Colorectal Cancer in Younger Patients May Have Prognostic Implications

PHILADELPHIA (June 26, 2019) – Researchers at Fox Chase Cancer Center have compared the genomic landscape of CRC in younger patients to older patients. Their analysis found differences in molecular carcinogenesis and may impact treatment decision-making.

Mark Sobczak, MD, FACR
June 19, 2019

Mark Sobczak Named a 2019 Fellow of the American College of Radiology

PHILADELPHIA (June 19, 2019)— Mark Sobczak, MD, FACR, clinical director in the Department of Radiation Oncology at Fox Chase Cancer Center, was selected as a 2019 Fellow of the American College of Radiology (ACR).

Study author Robert G. Uzzo, MD, FACS, Chair of the Department of Surgical Oncology at Fox Chase Cancer Center
June 19, 2019

Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care

PHILADELPHIA (June 19, 2019) — Many of the prediction models used by clinicians to guide patient care and clinical trial selection for solid tumors may not be as accurate as they are thought to be, according to a new study by researchers at Fox Chase Cancer Center.

June 18, 2019

Fox Chase Cancer Center Welcomes Assistant Professor Asya Varshavsky-Yanovsky

PHILADELPHIA (June 18, 2019) – Asya Varshavsky-Yanovsky, MD, PhD, will join the faculty as assistant professor in the Hematology and Bone Marrow Transplant Programs within the Department of Hematology/Oncology, on July 1, 2019.

Joseph R. Testa, PhD, FACMG
June 14, 2019

Common Mutations May Work in Tandem to Drive Development of Malignant Mesothelioma

PHILADELPHIA (June 14, 2019) – Researchers at Fox Chase Cancer Center have found that the combined loss of function of three genes commonly associated with pleural malignant mesothelioma – Bap1, Nf2, Cdkn2a – contributed to rapid and aggressive development of the disease in an animal study.

Pages

Connect with Fox Chase